Guardant Health
GH
#1043
Rank
A$32.86 B
Marketcap
A$244.87
Share price
-8.83%
Change (1 day)
154.24%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): A-$5.14

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$5.01. In 2025 the company made an earnings per share (EPS) of A-$4.75 an increase over its 2024 EPS that were of A-$5.11.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.148.3%
2025A-$4.75-7.02%
2024A-$5.11-16.82%
2023A-$6.14-33.12%
2022A-$9.1860%
2021A-$5.7455.04%
2020A-$3.70207.14%
2019A-$1.21-19.81%
2018A-$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$0.05162-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.51-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA